Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Greece.
Department of Dermatology, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
J Dermatol Sci. 2019 Jul;95(1):28-35. doi: 10.1016/j.jdermsci.2019.06.004. Epub 2019 Jun 16.
Netherton syndrome (NS) is a rare but severe type of ichthyosis characterized by atopy, allergies, and potentially lethal skin overdesquamation associated with highly elevated proteolytic activities in LEKTI-deficient epidermis. NS symptoms are recapitulated in Spink5 mouse where the gene encoding Lekti has been invalidated. Spink5 mice die within 5h from birth due to their severe skin barrier defect leading to dehydration. Spink5 mice also serve as a model for atopic dermatitis. The KLK6 protease is expressed by epidermal keratinocytes and shown in vitro to cleave desmosomal components.
To investigate in vivo whether KLK6 is implicated in epidermal overdesquamation and/or inflammation associated with NS.
The role of KLK6 was evaluated by generating Spink5Klk6 double knockout mice. The phenotype was assessed by macroscopic observation, immunohistochemistry for differentiation markers, in situ zymography for proteolysis, and quantification of proinflammatory cytokines.
Elimination of Klk6 in Spink5 remarkably suppresses the expression of Tslp, a major itching-inducing factor and driver of allergic reactions. Tnfα and the Th17 promoting cytokine Il-23 were also suppressed. Spink5Klk6 mice display normalized keratinocyte differentiation, nevertheless, epidermal proteolytic activities and the associated overdesquamation were not ameliorated, and Spink5Klk6 still died from a severe epidermal barrier defect as the Spink5.
Ablation of Klk6 largely suppresses epidermal inflammation but cannot rescue overdesquamation leading to the lethal NS phenotype. Nonetheless, our findings demonstrate for the first time that KLK6 is implicated in skin inflammation and may represent a novel druggable target for NS and other inflammatory conditions e.g. atopic dermatitis.
Netherton 综合征(NS)是一种罕见但严重的鱼鳞病,其特征为特应性、过敏和潜在致命的皮肤过度脱屑,与 LEKTI 缺陷表皮中高度升高的蛋白水解活性相关。缺失 Lekti 的基因 Spink5 小鼠中重现了 NS 症状。Spink5 小鼠出生后 5 小时内死亡,因为它们严重的皮肤屏障缺陷导致脱水。Spink5 小鼠也可用作特应性皮炎的模型。KLK6 蛋白酶由表皮角质形成细胞表达,并在体外显示可切割桥粒成分。
研究 KLK6 是否与 NS 相关的表皮过度脱屑和/或炎症有关。
通过生成 Spink5Klk6 双敲除小鼠来评估 KLK6 的作用。通过宏观观察、分化标志物的免疫组织化学、原位酶谱法用于蛋白水解和促炎细胞因子的定量来评估表型。
在 Spink5 中消除 Klk6 可显著抑制 Tslp 的表达,Tslp 是一种主要的瘙痒诱导因子和过敏反应的驱动因素。TNFα 和促进 Th17 的细胞因子 IL-23 也被抑制。Spink5Klk6 小鼠显示正常的角质形成细胞分化,但表皮蛋白水解活性和相关的过度脱屑没有得到改善,并且 Spink5Klk6 仍因严重的表皮屏障缺陷而死亡,就像 Spink5 一样。
Klk6 的缺失在很大程度上抑制了表皮炎症,但不能挽救过度脱屑导致致命的 NS 表型。尽管如此,我们的研究结果首次表明 KLK6 参与皮肤炎症,并且可能是 NS 和其他炎症性疾病(例如特应性皮炎)的新的可药物治疗的靶点。